Queensland and NT to stick with puberty blocker bans for transgender children against NHMRC advice
Özet haber: Queensland health minister Tim Nicholls says position on treatment ban in public hospitals ‘remains unchanged’ despite new guidelines

Queensland health minister Tim Nicholls says position on treatment ban in public hospitals ‘remains unchanged’ despite new guidelines
Get our breaking news email, free app or daily news podcast
The federal health minister, Mark Butler, says he’s confident Queensland and Northern Territory will consider the advice of Australia’s “pre-eminent authority” over their bans on puberty blockers for transgender children.
The federal government last year commissioned the commonwealth-funded National Health and Medical Research Council (NHMRC) to develop the advice in response to bans in public hospitals imposed by the two governments.
The NHMRC’s interim national clinical practice guidelines released on Monday advise the use of puberty suppressants for gender incongruence in children in certain circumstances.
Butler said the bans were a matter for the Queensland and the Northern Territory governments and the commonwealth could not intervene, but expected both governments to consider the guidelines.
“I am very confident that every state government, no matter their political persuasion, will consider the advice of our pre-eminent authority very closely,” he said.
But the Queensland health minister, Tim Nicholls, said the state government had “already undertaken an independent review and made a clear decision on the provision of these treatments in our public hospitals”.
“Our position remains unchanged and we will continue to prioritise the health, safety and wellbeing of young Queenslanders,” he said.
The Northern Territory government also said in a statement that its ban would continue, despite the advice.
Transgender Queenslander Betce Benjamin said the community would feel validation as a result of the interim advice and many were already celebrating.
“The number of people who’ve bombarded me today with happy exclamations of joy about this outcome [is extraordinary],” they said.
Benjamin said the bans had been harmful to young people in Queensland, but the true cost wouldn’t be known for years.
“I know of young people who have gone mute because their voices broke because they missed out on puberty blockers by a couple of weeks because of the ban,” they said.
The NHMRC explicitly rejected alternative approaches to gender-affirming care proposed by opponents of the approach – such as the “wait and see” model – as a form of withholding care for children, which it stated “can affect the young person’s physical and mental health, wellbeing, and ability to function”.
“Trans and gender-diverse young people experience unjust and avoidable health disparities arising from stigma, discrimination, and barriers to accessing health care,” it said.
Puberty blockers are a class of drugs used to stop the body producing oestrogen and testosterone.
They are covered by the Pharmaceutical Benefits Scheme for cisgender patients and have been used for decades.



